Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about PS: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
No AI portrait yet
Knowledge base pages for this entity
| Target | Relation | Type | Str |
|---|---|---|---|
| No outgoing edges | |||
Hypotheses where this entity is a therapeutic target
Scientific analyses that reference this entity
neurodegeneration | 2026-04-27 | 4 hypotheses Top: 0.760
neurodegeneration | 2026-04-27 | 4 hypotheses Top: 0.680
neurodegeneration | 2026-04-27 | 3 hypotheses Top: 0.626
neurodegeneration | 2026-04-16 | 1 hypotheses Top: 0.703
neurodegeneration | 2026-04-14 | 0 hypotheses
Experimental studies targeting or related to this entity
| Experiment | Type | Disease | Score | Feasibility | Model | Status | Est. Cost |
|---|---|---|---|---|---|---|---|
| Plant-based dietary patterns and Alzheimer's disease risk in multiethn | clinical | Alzheimer's disease and relate | 0.950 | 0.00 | human patients | proposed | N/A |
| Synaptic plasticity and protein expression analysis in mPFC | exploratory | insomnia-anxiety comorbidity | 0.850 | 0.00 | mPFC brain slices from PCPA-tr | proposed | N/A |
| Cholinergic System Dysfunction in DLB — Mechanisms and Therapeutic Res | clinical | Alzheimer's Disease | 0.400 | 0.50 | human | proposed | $5,460,000 |
| Mixed Pathology Effects on Parkinson's Disease Progression and Treatme | clinical | Alzheimer's Disease | 0.400 | 0.50 | human | proposed | $5,460,000 |
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| Clinical, Immunological, and Vesicular Markers in Sarcopenia and Presarcopenia. [PMID:40917056] | Shuliko LM, Svarovsky DA, Spirina LV, Og | Front Biosci (Landmark Ed) | 2025 | 1 |
| CD47-blocking antibody interferes with neutrophil extracellular traps formation [PMID:39951937] | Diao Y, Hao M, Xie M, Hu X, Tan R, Wang | J Neuroimmunol | 2025 | 1 |
| Asparagine Endopeptidase Inhibition Attenuates Tissue Plasminogen Activator-Indu [PMID:40116141] | Xie G, Jiang G, Huang L, Sun S, Li X, Wu | CNS Neurosci Ther | 2025 | 1 |
| Small molecule-driven NLRP3 inflammation inhibition via interplay between ubiqui [PMID:30966861] | ["Han X", "Sun S", "Sun Y", "Song Q", "Z | Autophagy | 2020 | 1 |
| Enhanced anticancer activity of nanoemulsified cardamom extract via modulation o [PMID:41658858] | ["Soltani T", "Karimian M", "Vaziri H", | Biochemistry and biophysics re | 2026 | 0 |
| Peripheral cancer attenuates amyloid pathology in Alzheimer's disease via cystat [PMID:41576952] | Li X, Tang X, Zeng J, Duan L, Hou Z et a | Cell | 2026 | 0 |
| Integrated transcriptomic, proteomic, and metabolomic analyses reveal molecular [PMID:41850064] | ["Wang H", "Liu Y", "Jiang K", "Yin J", | Poultry science | 2026 | 0 |
| Fragment merging design, synthesis, and biological evaluation of novel methyl Se [PMID:41785527] | ["Shaaban S", "Hawas S", "Elmaaty A", "B | Bioorganic & medicinal chemist | 2026 | 0 |
| Theranekron modulates extracellular matrix and apoptotic signaling pathways in c [PMID:41852375] | ["Kuccukturk S", "Duran T", "Vanli S", " | Cytotechnology | 2026 | 0 |
| Saliva liquid biopsy: MMP2, MMP9, and TIMP2 as potential diagnostic biomarkers i [PMID:41779471] | ["Cruz-Romero S", "Baldi\u00f3n A", "Taw | Journal of applied oral scienc | 2026 | 0 |
| Glomerular Transcriptome Analysis Reveals Endothelial Disturbances in Patients W [PMID:41659822] | ["Nelson-Taylor S", "Troost J", "Giannin | Kidney medicine | 2026 | 0 |
| Encapsulation of hydroxyurea in exosomes derived from adipose mesenchymal stem c [PMID:41702234] | ["Taheri Kangarshahi Z", "Ganji S", "Ash | Translational oncology | 2026 | 0 |
| NSUN2 promoted tumor growth and metastatic via m [PMID:41794778] | ["Li R", "Jin D", "Shao S", "Guo J"] | Cell death & disease | 2026 | 0 |
| Enhancing TREM2 expression activates microglia and modestly mitigates tau pathol [PMID:40122810] | ["Chen Kai", "Li Fuyao", "Zhang Shuwen", | Journal of neuroinflammation | 2025 | 0 |
| Licochalcone A prevents cognitive decline in a lipopolysaccharide-induced neuroi [PMID:39930360] | Carrasco M, Guzman L, Olloquequi J, Cano | Molecular medicine (Cambridge, | 2025 | 0 |
| Membrane-Type 5 Matrix Metalloproteinase (MT5-MMP): Background and Proposed Role [PMID:40867559] | ["Jadhav D", "Knapinska A", "Wang H", "F | Biomolecules | 2025 | 0 |
| Pyridostigmine Treatment Significantly Alleviates Isoprenaline-Induced Chronic H [PMID:40725139] | Marinković ST, Sobot T, Maksimović ŽM, Ð | International journal of molec | 2025 | 0 |
| Enhancing TREM2 expression activates microglia and modestly mitigates tau pathol [PMID:40122810] | ["Chen Kai", "Li Fuyao", "Zhang Shuwen", | Journal of neuroinflammation | 2025 | 0 |
| Effects of Mono- (2-ethylhexyl) phthalate and Phthalic Acid Monobenzyl Ester on [PMID:40769497] | ["Wu Q", "Sun Y", "Liu Q", "Zhao X", "Li | Reproductive toxicology (Elmsf | 2025 | 0 |
| Targeting Invasion: The Role of MMP-2 and MMP-9 Inhibition in Colorectal Cancer [PMID:39858430] | ["Shoari A", "Ashja Ardalan A", "Dimesa | Biomolecules | 2024 | 0 |
Multi-agent debates referencing this entity
closed · Rounds: 4 · Score: 0.67 · 2026-04-28
closed · Rounds: 4 · Score: 0.67 · 2026-04-28
closed · Rounds: 4 · Score: 0.67 · 2026-04-28
closed · Rounds: 4 · Score: 0.79 · 2026-04-21
closed · Rounds: 4 · Score: 0.44 · 2026-04-21
closed · Rounds: 4 · Score: 0.30 · 2026-04-21
closed · Rounds: 4 · Score: 0.84 · 2026-04-16
closed · Rounds: 4 · Score: 0.68 · 2026-04-16
closed · Rounds: 4 · Score: 0.68 · 2026-04-16
closed · Rounds: 4 · Score: 0.69 · 2026-04-12
Hypotheses and analyses mentioning PS in their description or question text
Score: 0.776 · neurodegeneration · 2026-04-16
## Mechanistic Overview CX3CR1-TREM2 Integration for Synapse Pruning Normalization starts from the claim that modulating
Score: 0.767 · neurodegeneration · 2026-04-17
## Mechanistic Overview Lysosomal Cathepsin-Dependent Tau Clearance starts from the claim that modulating not yet specif
Score: 0.763 · neurodegeneration · 2026-04-02
## Mechanistic Overview SASP-Mediated Cholinergic Synapse Disruption starts from the claim that modulating MMP2/MMP9 wit
Score: 0.760 · neurodegeneration · 2026-04-25
Oxidative DNA damage hyperactivates PARP1, rapidly consuming NAD+ and collapsing ATP production. Bioenergetic failure im
Score: 0.740 · neurodegeneration · 2026-04-21
## Mechanistic Overview VPS35 retromer activation prevents endosomal tau templating across all brain regions and disease
Score: 0.737 · neurodegeneration · 2026-04-22
**Molecular Mechanism and Rationale** The central molecular mechanism underlying this hypothesis involves the intricate
Score: 0.730 · neurodegeneration · 2026-04-22
**Molecular Mechanism and Rationale** The pathophysiology of neurodegeneration in layer II stellate cells centers on dy
Score: 0.730 · neurodegeneration · 2026-04-25
AD-risk trafficking defects in SORL1/BIN1/PICALM/retromer may generate parallel early outputs: amyloidogenic APP sorting
Score: 0.724 · neurodegeneration · 2026-04-13
**Molecular Mechanism and Rationale** The molecular cascade underlying TBK1 loss-of-function-mediated synapse eliminati
Score: 0.720 · neurodegeneration · 2026-04-25
In APOE4 contexts, reduced LRP1 signaling in PDGFRB+ pericytes permits activation of the PPIA/CypA-MMP9 axis, leading to
Score: 0.703 · neurodegeneration · 2026-04-16
**Molecular Mechanism and Rationale** The pathogenesis of Parkinson's disease (PD) involves complex interactions betwee
Score: 0.682 · als · 2026-04-27
CCR2+ monocyte-derived macrophages, recruited to the neuromuscular junction by motor neuron-secreted CCL2, selectively i